Sidebar Ads

Wednesday, February 28, 2018

Valeant revenue forecast misses estimates as competition heats up

(Reuters) - Valeant Pharmaceuticals' forecast for 2018 revenue fell below Wall Street estimates, as the company faces intensifying competition for some of its major products.


from Reuters: Business News http://ift.tt/2F2iMA5

0 comments:

Post a Comment

Portugal and Italy will not suspend digital border checks for Brits

Reports had suggested the countries were set to follow the example of Greece, which effectively suspended biometric checks for UK nationals....